Bio & Science

Latest

Mid-year Recap: Web3 and Science Collide

Nicole Neuman

The first half of 2022 saw momentum gains for a movement at the intersection of web3 and science: decentralized science (DeSci).

Recognizing the Next CRISPR-Level Tech for Biology

Jennifer Doudna and Vijay Pande

A Q&A with Jennifer Doudna. She shares thoughts on recognizing game-changing biology tools, what she's struggling with, and what may never be engineerable.

The Two Things We’ll Need for the Next AlphaFold

Daphne Koller and Nicole Neuman

Daphne Koller explains why some fail the academia-to-biotech transition and identifies what we'll need for AlphaFold-level successes across biology and biotech.

Can Synthetic Biology and Pond Scum Deliver Carbon-Neutral Manufacturing?

Nusqe Spanton and Nicole Neuman

A Q&A with Nusqe Spanton, founder and CEO of Provectus Algae.

A Guide to Decentralized Biotech

Jocelynn Pearl

Shared lab space, collaborative projects, DAO-funded research, and other signs of big structural change in this traditionally centralized industry.

The Age of Tech x Bio: The ‘Industrial Bio Complex’

Vijay Pande

A new era of industrialized bio is the next industrial revolution, propelled forward by Covid as our gen’s World War II. And with it we'll now see bio's GAFA...

Global Labs Pose Major Threat — Here’s What U.S. Should Do

Scott Gottlieb

Labs classified as BSL-4 are being built all around the world, many in countries with a history of poor controls and oversight of research practices.

Uncontrolled Spread: Science, Policy, Institutions, Infrastructure

Scott Gottlieb, Vineeta Agarwala, Marc Andreessen, and Vijay Pande

We were at an inflection point with the COVID pandemic, between old and new tech, science institutions, policy, more. So what can we learn from past for future?

The Average American Would Pay $242,000 For One Extra Year of Good Health

Andrew Scott

New economic research supports a shift from the pursuit of longevity at all costs to a focus on healthspan: more healthy time over the duration of one’s life.

The Therapist Will See You Now. But Where?

Hannah Zeavin

As therapists and patients debate a return to the physical office, both must consider the newly discovered advantages of "distanced intimacy."